June 03, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Bempedoic acid may prevent dangerous blood clots from forming in addition to reducing risk for major cardiovascular events vs. placebo in statin-intolerant people with prior CVD or at high risk for it, researchers reported.Bempedoic acid (Nexletol, Esperion Therapeutics) significantly reduced risk for venous thromboembolism, including both deep vein thrombosis and pulmonary embolism, compared
June 03, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

In high-risk patients without prior heart attack or stroke who underwent percutaneous coronary intervention, evolocumab reduced…

Genetic PCSK9 inhibition via base editing appeared safe and demonstrated dose-dependent, durable reductions in PCSK9 and LDL…

In adults with prior preventive migraine treatment failures, an investigational monoclonal antibody led to larger decreases in…

Up to 21.5 million additional U.S. adults may be considered eligible for statin therapy based on newly updated dyslipidemia…

Finerenone was associated with early and sustained reductions in systolic blood pressure among patients with heart failure with…

Repatha is the Only PCSK9 Inhibitor Proven to Significantly Reduce Risk of First Heart Attack and Stroke in Phase 3 Clinical…